References
- Ablondi F. E., De Reinzo E. G. Mechanism of clot lysis, by streptptokinase and effect of epsilon-aminocaproic acid. Proc. Soc. exp. Biol. 1959; 102: 717
- Hagan J. J., Philops M., De Renzo E. G. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by epsilon-aminocaproic acid. Arch. Biochem. 1959; 83: 153
- Alagille D., Soulier J. P. Action des enzymes proteolytiques sur le song total “in, vitro”. Modifications des facteulrs de coagulation et du complement Semaine hop. Paris. 32 1956; 7: 355
- Alkjaersig N., Fletchder A. P., Sherry S. a) The mechanism of clot dissolution by plasmin. J. Chin. Investigation 1959; 38: 1086
- Epsilon amino caproic acid: an inhibitor of plasminogen activation. J. biol. Chem. 1959; 234: 832
- Coon W. W., Duff I. F. Effects of intravenous human plasmin on the blood clotting mechanism of the dog. J. Lab. clin. Med. 1958; 51: 381
- Deutsch E. Eine eiafache Method, zur Bestimmung von Thromibozytenfaktor 4. Thromb. Diath. haem. 1959; 4: 93
- Deutsch E., Jürgens J. Methoden der Blutgerinnungsanalyse, J. Jürgenus, F. K. Beller, Klinische. Thieme, Stuttgart, 149
- Dedsch E., Fischer M. Die Wirkmg intravenös applizierter Streptokinase auf Fibrinolyse und Blutgerinung. Thromb. Diath. haem. 1960; 4: 482
- Fletcher A. P., Alkjaersig N., Sherry S. Pathogenesis of the hemorrhagic diathesis developing during “fibrinolytic” states: The significance of defective fibrin polymerization. J. clin. Invest. 1959; 38: 1035
- Glas P., Beller F. K. Inhibition of clotting as the result of plsaminogen activation by streptokinase. I) Studies of the inactivation of fibrinogen. Thromb. Diath. haem. 1960; 4: 507, 520, 11) Analyltical studies of the clotting mechanism. Ibid. 1960 4
- Holger-Madsen T. The plasma heparin thrombin time. Acta haemat. 1959; 21: 301
- Holger-Madsen T., SchiØler M. Heparin resistance, measured by the plasma heparin thrombin time, h patients of longterm anticoagulant therapy with phenylindanedione following coronary occlusion. Thromb. Dhh. haw. 1960; 4: 261
- Innenfield I. Plasma antithrombin elevations in buccal Varidase-treated patients. Surgery 1956; 43: 956
- Jung E. G., Duckert F. Wirkung von Plasmin (Fibrinolylsin) auf die Gerinmngsfaktorrea; Schweiz. med Wschr. 1960; 44: 1239
- Koller F. Fibrinolyse. Ibid. 1960; 44: 1233
- Niewimwski S., Kowaldai E., Stacursh J. Influence of the fibrinogen derived antithrombin (anthrombin VI) on the blood coagulation system. Acta biochim. pol. 1959; 6: 43
- Peden J. C., MacFarlane J. A. Use of the plasma thrombin time to assess the adequacy of in vivo neutralization of heparin: comparative studies following operations employing a-tracorporeal circulation. Blood 1959; 14: 1230
- Triantaphyllopoulos D. C. Nature of the thrombin-inhibiting effect of incubated fibrinogen. Amer. J. Physiol. 1959; 197: 575